You have 8 free searches left this month | for more free features.

Cardiovascular Disease, Unspecified

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Recruiting
  • Fatty Liver Disease
  • Fibrotouch
  • Beijing, Bejing, China
    Bejing Tsinghua Chang Gung Hospital
Jun 13, 2022

Longitudinal Study for Central Nervous System Vasculitis

Not yet recruiting
  • Central Nervous System Vasculitis
  • +3 more
    • Cleveland, Ohio
    • +1 more
    Feb 8, 2023

    Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,

    Terminated
    • Hematopoietic Stem Cell Transplantation
    • +4 more
    • Duarte, California
    • +3 more
    Oct 18, 2022

    Colorectal Cancer, Lung Cancer, Solid Tumor Trial in Ottawa, Toronto (capecitabine, carboplatin, cediranib maleate)

    Completed
    • Colorectal Cancer
    • +2 more
    • Ottawa, Ontario, Canada
    • +1 more
    Mar 14, 2022

    Nonalcoholic Steatohepatitis (NASH) With Fibrosis Trial in Worldwide (Elafibranor, Placebo)

    Terminated
    • Nonalcoholic Steatohepatitis (NASH) With Fibrosis
    • Birmingham, Alabama
    • +325 more
    Feb 25, 2022

    Hyperthyroidism, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)

    Not yet recruiting
    • Hyperthyroidism
    • +2 more
    • Patient Participation Form
    • (no location specified)
    Feb 25, 2023

    Hypothyroidism, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)

    Not yet recruiting
    • Hypothyroidism
    • +2 more
    • Patient Participation Form
    • (no location specified)
    Feb 26, 2023

    Osteoporosis, Osteoporosis Risk, Ankylosing Spondylitis Trial (Patient Participation Form)

    Not yet recruiting
    • Osteoporosis
    • +2 more
    • Patient Participation Form
    • (no location specified)
    Feb 26, 2023

    Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial (Patient Participation Form)

    Not yet recruiting
    • Diabetes Mellitus
    • +4 more
    • Patient Participation Form
    • (no location specified)
    Feb 26, 2023

    Multiple Sclerosis, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • Patient Participation Form
    • (no location specified)
    Feb 25, 2023

    A Randomised Controlled Trial

    Active, not recruiting
    • Diabetes
    • Chronic Kidney Diseases
    • Minuteful Kidney Test Kit
    • Essex, United Kingdom
    • +5 more
    Jul 20, 2023

    IgA Nephropathy Trial in Shanghai

    Recruiting
    • IgA Nephropathy
      • Shanghai, Shanghai, China
        Ruijin Hospital, Shanghai JiaoTong University School of Medicine
      Nov 1, 2022

      Hypertension Secondary to Renal Disease Trial in Vaasa (Renal nerve denervation)

      Terminated
      • Hypertension Secondary to Renal Disease
      • Renal nerve denervation
      • Vaasa, Finland
        Vaasa Central Hospital
      Mar 8, 2021

      Lung Diseases, Interstitial Trial in Sydney, Brisbane, Melbourne (Pulmonary Fibrosis self-management package and smartphone

      Not yet recruiting
      • Lung Diseases, Interstitial
      • Pulmonary Fibrosis self-management package and smartphone application
      • Sydney, New South Wales, Australia
      • +3 more
      Nov 2, 2023

      Valvular Heart Disease Trial in Hangzhou (Our study type is observational)

      Recruiting
      • Valvular Heart Disease
      • Our study type is observational
      • Hangzhou, Zhejiang, China
        Second Affiliated Hospital Zhejiang University School of Medicin
      Jul 14, 2021

      Physical Disability, Cognitive Dysfunction Trial in Takarazuka (mediVR KAGURA)

      Completed
      • Physical Disability
      • Cognitive Dysfunction
      • mediVR KAGURA
      • Takarazuka, Hyogo, Japan
        Cloud Clinic
      Aug 14, 2022

      Hyperlipidemia, Mixed Dyslipidemia Trial in Denver (Evolocumab)

      Completed
      • Hyperlipidemia
      • Mixed Dyslipidemia
      • Evolocumab
      • Denver, Colorado
        Research Site
      Nov 3, 2022

      Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Ocrelizumab)

      Completed
      • Multiple Sclerosis, Relapsing-Remitting
      • Ocrelizumab
      • Kogarah, New South Wales, New South Wales, Australia
      • +162 more
      Jan 25, 2022

      Sphingo-lipotoxicity and Trans-differentiation of Adipose Tissue

      Completed
      • Obesity
      • Healthy
      • Blood sample collection
      • Oggebbio, Verbania, Italy
        Istituto Auxologico Italiano, Site Piancavallo
      Mar 9, 2023

      Natural History of Disease in Patients Treated With Radiotherapy

      Recruiting
      • Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Gait Disorders, Neurologic, Parkinson Disease Trial in Créteil (Gait training with musical cue)

        Completed
        • Gait Disorders, Neurologic
        • Parkinson Disease
        • Gait training with musical cue
        • Créteil, France
          Laboratoire Analyse et Restauration du Mouvement
        Oct 14, 2022

        HIV, HIV Trial (Dolutegravir, Lamivudine, Bictegravir)

        Not yet recruiting
        • HIV
        • HIV Infections
        • (no location specified)
        Aug 4, 2023

        COVID-19 Disease Trial in Canada, United States (LAU-7b, Placebo oral capsule)

        Recruiting
        • COVID-19 Disease
        • Chandler, Arizona
        • +28 more
        Aug 19, 2022

        Atopic Dermatitis Trial in France (Cholecalciferol, Placebo of cholecalciferol)

        Active, not recruiting
        • Atopic Dermatitis
        • Bordeaux, France
        • +10 more
        Aug 19, 2022

        Lung Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Placebo)

        Completed
        • Lung Cancer
        • Nivolumab
        • +2 more
        • Sacramento, California
        • +195 more
        Jan 25, 2022